Security key
800677106
SANGAMO THERAPEUTICS, INC - Common Stock, $0.01 par value per share (SGMO)
CUSIP: 800677106
Q2 2018 13F Holders as of 30 Jun 2018
- Type / Class
- Equity / Common Stock, $0.01 par value per share
- Shares outstanding
- 414,359,662
- Total 13F shares
- 64,727,770
- Share change
- +7,741,879
- Total reported value
- $919,122,586
- Put/Call ratio
- 107%
- Price per share
- $14.20
- Number of holders
- 206
- Value change
- +$101,709,560
- Number of buys
- 131
- Number of sells
- 80
Report period
Q2 2018
Institutions
206
Top holders
10
SGMO full security history
Newer quarter: Q3 2018
Previous quarter: Q1 2018
SANGAMO THERAPEUTICS, INC SEC filings
SANGAMO THERAPEUTICS, INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 800677106
Recent filing periods:
Top shareholders of SGMO - SANGAMO THERAPEUTICS, INC - Common Stock, $0.01 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
1.7%
|
6,943,424
|
$131,924,000 | — | 31 Mar 2018 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.6%
|
6,692,054
|
$127,150,000 | — | 31 Mar 2018 | |
| STATE STREET CORP |
13F
|
Company |
1.1%
|
4,536,951
|
$86,206,000 | — | 31 Mar 2018 | |
| FMR LLC |
13F
|
Company |
1%
|
4,251,459
|
$80,778,000 | — | 31 Mar 2018 | |
| WASATCH ADVISORS LP |
13F
|
Company |
0.89%
|
3,692,981
|
$70,167,000 | — | 31 Mar 2018 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.56%
|
2,300,000
|
$43,700,000 | — | 31 Mar 2018 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.47%
|
1,934,665
|
$36,760,000 | — | 31 Mar 2018 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.39%
|
1,607,579
|
$30,544,000 | — | 31 Mar 2018 | |
| Casdin Capital, LLC |
13F
|
Company |
0.34%
|
1,400,000
|
$26,600,000 | — | 31 Mar 2018 | |
| MORGAN STANLEY |
13F
|
Company |
0.3%
|
1,240,739
|
$23,574,000 | — | 31 Mar 2018 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.26%
|
1,063,930
|
$20,215,000 | — | 31 Mar 2018 | |
| Invesco Ltd. |
13F
|
Company |
0.24%
|
1,000,763
|
$19,015,000 | — | 31 Mar 2018 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.22%
|
908,787
|
$17,267,000 | — | 31 Mar 2018 | |
| Alexandria Capital, LLC |
13F
|
Company |
0.21%
|
881,533
|
$16,749,000 | — | 31 Mar 2018 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.2%
|
837,995
|
$15,921,000 | — | 31 Mar 2018 | |
| NEXTHERA CAPITAL LP |
13F
|
Company |
0.19%
|
786,376
|
$14,941,000 | — | 31 Mar 2018 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.17%
|
698,920
|
$13,279,000 | — | 31 Mar 2018 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.15%
|
620,103
|
$11,781,957 | — | 31 Mar 2018 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.14%
|
584,538
|
$11,106,000 | — | 31 Mar 2018 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.13%
|
555,635
|
$10,556,000 | — | 31 Mar 2018 | |
| Opaleye Management Inc. |
13F
|
Company |
0.13%
|
535,000
|
$10,165,000 | — | 31 Mar 2018 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.12%
|
505,536
|
$9,605,000 | — | 31 Mar 2018 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.12%
|
497,227
|
$9,445,000 | — | 31 Mar 2018 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.12%
|
494,467
|
$9,395,000 | — | 31 Mar 2018 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
0.11%
|
475,388
|
$9,032,000 | — | 31 Mar 2018 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.11%
|
463,847
|
$8,814,000 | — | 31 Mar 2018 | |
| PDT Partners, LLC |
13F
|
Company |
0.11%
|
454,436
|
$8,634,000 | — | 31 Mar 2018 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.1%
|
426,822
|
$8,110,000 | — | 31 Mar 2018 | |
| PEREGRINE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.1%
|
400,406
|
$7,608,000 | — | 31 Mar 2018 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.09%
|
382,192
|
$7,262,000 | — | 31 Mar 2018 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.08%
|
330,141
|
$6,273,000 | — | 31 Mar 2018 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.08%
|
326,275
|
$6,199,000 | — | 31 Mar 2018 | |
| TOCQUEVILLE ASSET MANAGEMENT L.P. |
13F
|
Company |
0.07%
|
310,240
|
$5,895,000 | — | 31 Mar 2018 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.06%
|
255,793
|
$4,860,000 | — | 31 Mar 2018 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.06%
|
245,655
|
$4,667,000 | — | 31 Mar 2018 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.06%
|
243,642
|
$4,629,000 | — | 31 Mar 2018 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.06%
|
234,064
|
$4,447,000 | — | 31 Mar 2018 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.06%
|
230,252
|
$4,375,000 | — | 31 Mar 2018 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.05%
|
219,415
|
$4,169,000 | — | 31 Mar 2018 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.05%
|
217,190
|
$4,127,000 | — | 31 Mar 2018 | |
| ALTRINSIC GLOBAL ADVISORS LLC |
13F
|
Company |
0.05%
|
210,000
|
$3,990,000 | — | 31 Mar 2018 | |
| UBS Group AG |
13F
|
Company |
0.05%
|
208,744
|
$3,966,000 | — | 31 Mar 2018 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.04%
|
184,665
|
$3,509,000 | — | 31 Mar 2018 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.04%
|
183,716
|
$3,491,000 | — | 31 Mar 2018 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.04%
|
179,803
|
$3,416,000 | — | 31 Mar 2018 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.04%
|
176,017
|
$3,344,000 | — | 31 Mar 2018 | |
| Foresite Capital Management III, LLC |
13F
|
Company |
0.04%
|
154,462
|
$2,935,000 | — | 31 Mar 2018 | |
| A.R.T. Advisors, LLC |
13F
|
Company |
0.04%
|
154,406
|
$2,933,000 | — | 31 Mar 2018 | |
| Artal Group S.A. |
13F
|
Company |
0.04%
|
150,000
|
$2,850,000 | — | 31 Mar 2018 | |
| Swiss National Bank |
13F
|
Company |
0.04%
|
145,360
|
$2,762,000 | — | 31 Mar 2018 |
Institutional Holders of SANGAMO THERAPEUTICS, INC - Common Stock, $0.01 par value per share (SGMO) as of Q2 2018
As of 30 Jun 2018,
SANGAMO THERAPEUTICS, INC - Common Stock, $0.01 par value per share (SGMO) was held by
206 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
64,727,770 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, WASATCH ADVISORS INC, FMR LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., CREDIT SUISSE AG/, EcoR1 Capital, LLC, Casdin Capital, LLC, and NORTHERN TRUST CORP.
This page lists
206
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2018 vs Q1 2018 Across Filers
Q1 2018 holders
205
Q2 2018 holders
206
Holder diff
1
| Investor | Q1 2018 Shares | Q2 2018 Shares | Share Diff | Share Chg % | Q1 2018 Value $ | Q2 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.